exRNA Therapeutics
PrivateLast Round
Accelerator
Jun 3, 2022
Company Overview
exRNA Therapeutics is a biotechnology company that specializes in the research and development of RNA-based therapeutics, including antisense oligonucleotide therapies and RNA interference solutions, to address rare, neurological, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
exRNA Therapeutics Comparables
Compare exRNA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tevard Biosciences | 76% | |
| HAYA Therapeutics | 72% | |
| Alltrna | 70% | |
exRNA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 3, 2022 |
exRNA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ASPIRE-BioNEST | Accelerator |
exRNA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about exRNA Therapeutics's valuation, stock price, and market status.